A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment Before
Condition: Chronic Hepatitis C InfectionInterventions: Drug: ABT-450/r/ABT-267; Drug: ABT-333; Drug: Ribavirin; Drug: Telaprevir; Drug: Pegylated Interferon alpha 2-alpha (PegIFN)Sponsor: AbbVieActive, not recruiting - verified April 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials